Document Details
Form
Filing Date
Jan 25, 2024
Document Date
Jan 25, 2024
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
ArriVent Biopharma
Issuer
ARRIVENT BIOPHARMA, INC.